Unconfigured Ad

Collapse

New here? Stop in and introduce yourself. Where you are, what you work on, etc.

Forums Topics Posts Last Post
No forums found.
  •  
  • Filter
  • Time
  • Answered
  • Show
  • New Topics
Clear All
new posts
There are no conversations in this channel.
 
  • Filter
  • Time
  • Show
Clear All
new posts
Please log in to your account to view your subscribed posts.
  •  
  • Filter
  • Time
  • Answered
  • Show
  • Sort By
  • Order
Clear All
new posts
Topics Statistics Last Post
Started by ECO, 11-21-2011, 08:25 PM
16 responses
55,157 views
0 reactions
Last Post plant_hunt  
Started by tyfach, 11-03-2011, 01:25 AM
0 responses
1,630 views
0 reactions
Last Post tyfach
by tyfach
 
Started by CaptSolo, 11-02-2011, 03:57 PM
0 responses
1,165 views
0 reactions
Last Post CaptSolo  
Started by Jim Robinson, 01-09-2010, 07:09 PM
33 responses
10,780 views
0 reactions
Last Post Jim Robinson  
Started by ThoralfStange, 11-02-2011, 03:31 AM
0 responses
1,438 views
0 reactions
Last Post ThoralfStange  
Started by albraylee, 11-01-2011, 05:49 PM
0 responses
1,707 views
0 reactions
Last Post albraylee  
Started by paulsydney, 11-01-2011, 05:42 PM
0 responses
2,541 views
0 reactions
Last Post paulsydney  
Hi by dgg32
Started by dgg32, 10-30-2011, 02:47 PM
1 response
1,240 views
0 reactions
Last Post redspide  
Started by geschickten, 10-30-2011, 06:51 AM
0 responses
2,928 views
0 reactions
Last Post geschickten  
Hi by kepbod
Started by kepbod, 10-29-2011, 11:20 PM
0 responses
1,056 views
0 reactions
Last Post kepbod
by kepbod
 
hi by griffes
Started by griffes, 10-28-2011, 07:55 PM
0 responses
1,172 views
0 reactions
Last Post griffes
by griffes
 
No topics found.
  • Filter
  • Time
Clear All
widgetinstance 229 (Webinars) skipped due to lack of content & hide_module_if_empty option.

Recent Articles

Collapse

  • mylaser
    Reply to Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
    by mylaser
    Kheloyar – Everything You Need to Know About Kheloyaar Login and Kheoyar Id
    If you are looking for an online gaming platform that offers a user-friendly experience, Kheloyar has become a name that many users search for. Whether you're interested in creating a new account, accessing your dashboard through Kheloyaar Login, or learning how to obtain a Kheoyar Id, understanding the platform's features and account process is essential.
    This guide explains everything you need to know about...
    Yesterday, 01:13 AM
  • SEQadmin2
    Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
    by SEQadmin2



    Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
    ...
    07-09-2026, 11:10 AM
  • SEQadmin2
    Cancer Drug Resistance: The Lingering Barrier to Rising Survival
    by SEQadmin2



    Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.

    There is no single reason why many patients don’t respond to treatment as expected. Cancer is...
    07-08-2026, 05:17 AM

ad_right_rmr

Collapse

News

Collapse

Topics Statistics Last Post
Started by SEQadmin2, 07-09-2026, 10:04 AM
0 responses
20 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 07-08-2026, 10:08 AM
0 responses
12 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 07-07-2026, 11:05 AM
0 responses
30 views
0 reactions
Last Post SEQadmin2  
Working...